Publicaciones (29) Publicaciones de RITA GARCÍA MARTÍNEZ

2024

  1. Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis

    JHEP Reports, Vol. 6, Núm. 2

2023

  1. Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital

    Revista Espanola de Quimioterapia, Vol. 26, Núm. 1, pp. 45-51

2022

  1. Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study

    European Journal of Neurology, Vol. 29, Núm. 2, pp. 400-412

  2. Management of Hepatic Encephalopathy Associated with Advanced Liver Disease

    Clinical Drug Investigation, Vol. 42, pp. 5-13

2021

  1. Different within-host viral evolution dynamics in severely immunosuppressed cases with persistent sars-cov-2

    Biomedicines, Vol. 9, Núm. 7

  2. Impact of lifestyle interventions targeting physical exercise and caloric intake on cirrhosis regression in rats

    American Journal of Physiology - Gastrointestinal and Liver Physiology, Vol. 321, Núm. 6, pp. G603-G616

  3. Microscopic lymphocytic colitis due to duloxetine: Case report and review of the literature

    Gastroenterologia y Hepatologia, Vol. 44, Núm. 3, pp. 222-223

2018

  1. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis

    Gastroenterology, Vol. 154, Núm. 6, pp. 1694-1705.e4

  2. Midodrine and albumin for prevention of complications in patients with cirrhosis awaiting liver transplantation. A randomized placebo-controlled trial

    Journal of Hepatology, Vol. 69, Núm. 6, pp. 1250-1259

2017

  1. Refractory hepatic encephalopathy in a patient with hypothyroiDism: Another element in ammonia metabolism

    World Journal of Gastroenterology, Vol. 23, Núm. 28, pp. 5246-5252

2015

  1. Albumin infusion improves renal blood flow autoregulation in patients with acute decompensation of cirrhosis and acute kidney injury

    Liver International, Vol. 35, Núm. 2, pp. 335-343

  2. Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure

    Journal of Hepatology, Vol. 62, Núm. 4, pp. 799-806

2014

  1. Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Journal of Hepatology

  2. Human serum albumin, systemic inflammation, and cirrhosis

    Journal of Hepatology, Vol. 61, Núm. 2, pp. 396-407

  3. Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2

    Nature Medicine, Vol. 20, Núm. 5, pp. 518-523

2013

  1. Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications

    Hepatology, Vol. 58, Núm. 5, pp. 1836-1846

  2. Brain magnetic resonance spectroscopy in episodic hepatic encephalopathy

    Journal of Cerebral Blood Flow and Metabolism, Vol. 33, Núm. 2, pp. 272-277

  3. Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: A randomized double-blind study

    Journal of Hepatology, Vol. 59, Núm. 6, pp. 1184-1192

2012

  1. Brain imaging in hepatic encephalopathy

    Hepatic Encephalopathy (Humana Press Inc.), pp. 123-136

  2. Liver-induced inflammation hurts the brain

    Journal of Hepatology